The above chart presents the market trend analysis for sannovex pharmaceutical distributors from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 37 transactions, with a transaction quantity of 84305.99 and a transaction weight of 91171.35.
Product description
216000.00 BOXES (CEFUVEX) CEFUROXIME SODIUM FOR INJECTION BATCH NUMBER 251214 EXPIRY DATE 2028/11 (BRAND NAME CEFUVEX GENERIC NAME CEFUROXIME (AS SODIUM)
Expand
Trade date
2026/02/04
B/L No.
sitrtxmn583088
Suppliers
ncpc international corp.
Buyers
sannovex pharmaceutical distributors
POLs
——
PODs
manila international container terminal
Product description
89060.00 VIALS OMEVEX OMEPRAZOLE (AS SODUIM) 40 MG LYOPHILIZED POWDER FOR IV INFUSION FDA REGISTRATION NO DRP-2822 BOX OF 10 VIALS (BRAND NAME OMEVEX GENERIC NAME OMEPRAZOLE (AS SODIUM)
Expand
Product description
34940.00 VIALS CEFUROXIME SODIUM FOR INJECTION 1.5G MARK CEFUVEX BATCH NO C5B11011 MFG DATE NOV.2025 EXPIRY DATE OCT.2027 (BRAND NAME CEFUVEX GENERIC NAME CEFUROXIME (AS SODIUM))
Expand
Product description
94200.00 BX (TAZIVEX) CEFTAZIDIME FOR INJECTION BATCH NUMBER 251086 EXPIRY DATE 2028/09 (BRAND NAME TAZIVEX GENERIC NAME CEFTAZIDIME)
Expand
sannovex pharmaceutical distributors is philippines Buyer,
and primarily engages in the import and export business of products such as brand name,generic name,vial.
According to the 52wmb.com global trade database, as of 2026-02-20, the company has completed 441 international trades,
with its main trading regions covering china,philippines,romania etc.
The core products include HS30049099000,HS30041019000,HS30042099000 etc,
often transported via manila international container terminal,port manila, port port of manila etc,
and its main trading partners are ncpc international corp.,yuria pharm ltd,shandong xier kangtai pharma.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on sannovex pharmaceutical distributors is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.